SHORT COURSE PROMACE-CYTABOM FOR STAGES II-IV DIFFUSE AGGRESSIVE LYMPHOMA
SHORT COURSE PROMACE-CYTABOM FOR STAGES II-IV DIFFUSE AGGRESSIVE LYMPHOMA
批准号:
3874545
负责人:
D L LONGO
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
antineoplastics bleomycin clinical trials combination chemotherapy cyclophosphamide cytosine arabinoside dosage doxorubicin etoposide human subject human therapy evaluation human tissue lymphoma methotrexate neoplasm /cancer chemotherapy neoplasm /cancer classification /staging neoplasm /cancer relapse /recurrence prednisone remission /regression vincristine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This study was designed as a pilot study to test the feasibility and
efficacy of administering a dose-intense version of a standard combination
chemotherapy regimen ProMACE-CytaBOM for patients with Stages II, III, and
IV diffuse aggression lymphoma. The treatment consists of eight 2-week
cycles, for a total of sixteen weeks. To date, there have been 23
evaluable patients entered on study: nineteen have achieved a complete
response (83%). There have been 6 relapses (32%), all following short
complete remissions. In conclusion, these preliminary results indicate
that the treatment can be safely given, though some patients require dose-
reductions. Early response rates are equivalent to standard ProMACE-
CytaBOM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TREATMENT OF B-CELL LYMPHOMAS WITH ANTI-B4-BLOCKED RICIN IMMUNOCONJUGATE
-
批准号:3838244
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
MOPP VS RADIOTHERAPY FOR EARLY STAGE HODGKIN'S DISEASE
-
批准号:3838209
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
5FU, LEUCOVORIN, AZT & PERSANTINE FOR MELANOMA, RENAL, AND COLORECTAL CANCER
-
批准号:3838218
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
TREATMENT OF STAGE I DIFFUSE AGGRESSIVE LYMPHOMAS
-
批准号:3853324
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
PROMACE-CYTABOM TREATMENT FOR ANGIOCENTRIC IMMUNOPROLIFERATIVE LESIONS
-
批准号:3874549
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
MOPP/ABVD FOLLOWED BY RADIOTHERAPY FOR MASSIVE MEDIASTINAL HODGKIN'S DISEASE
-
批准号:3896350
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
MOPP VERSUS RADIOTHERAPY FOR EARLY STAGE HODGKIN'S DISEASE
-
批准号:3752488
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
TREATMENT OF B-CELL LYMPHOMAS WITH ANTI-B4-BLOCKED RICIN IMMUNOCONJUGATE
-
批准号:3752511
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
PROMACE-CYTABOM TREATMENT FOR ANGIOCENTRIC IMMUNOPROLIFERATIVE LESIONS
-
批准号:3752490
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
CYTOKINES AND STEM CELL TRANSPLANTATION FOR REFRACTORY LYMPHOMAS
-
批准号:3752506
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
DOSE INTENSE MOPP FOR PATIENTS WITH POOR PROGNOSIS HODGKIN'S DISEASE
-
批准号:3874546
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
CYTOKINES AND STEM CELL TRANSPLANTATION FOR REFRACTORY LYMPHOMAS
-
批准号:3838237
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
SHORT COURSE PROMACE-CYTABOM FOR STAGES II-IV DIFFUSE AGGRESSIVE LYMPHOMA
-
批准号:3838207
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
PROMACE-CYTABOM TREATMENT FOR ANGIOCENTRIC IMMUNOPROLIFERATIVE LESIONS
-
批准号:3838211
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
GENETIC REGULATION OF THE IMMUNE RESPONSE
-
批准号:4692161
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
MOPP VS RADIOTHERAPY FOR EARLY STAGE HODGKIN'S DISEASE
-
批准号:3853321
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
5FU, LEUCOVORIN, AZT & PERSANTINE FOR MELANOMA, RENAL, AND COLORECTAL CANCER
-
批准号:3853330
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
OBSERVATION VS. INTENSIVE CHEMOTHERAPY FOR INDOLENT LYMPHOMA
-
批准号:3853322
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
OBSERVATION VS. INTENSIVE CHEMOTHERAPY FOR INDOLENT LYMPHOMA
-
批准号:3874548
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
PHASE I TRIAL OF ANTI-CD3 MONOCLONAL ANTIBODIES IN PATIENTS WITH ADVANCED CANCER
-
批准号:3874543
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D L LONGO
-
依托单位:
海外基金